Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 243

1.

Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.

Liu C, Xia X, Wu W, Wu R, Tang M, Chen T, Xu F, Cong Y, Xu X, Liu Z.

Clin Exp Immunol. 2013 Jul;173(1):102-11. doi: 10.1111/cei.12084.

PMID:
23607532
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.

Su J, Chen T, Ji XY, Liu C, Yadav PK, Wu R, Yang P, Liu Z.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):720-8. doi: 10.1097/MIB.0b013e3182802a76.

PMID:
23429464
[PubMed - indexed for MEDLINE]
3.

Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.

Caprioli F, Bosè F, Rossi RL, Petti L, Viganò C, Ciafardini C, Raeli L, Basilisco G, Ferrero S, Pagani M, Conte D, Altomare G, Monteleone G, Abrignani S, Reali E.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):729-39. doi: 10.1097/MIB.0b013e318280292b.

PMID:
23448791
[PubMed - indexed for MEDLINE]
4.

Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.

Ogino T, Nishimura J, Barman S, Kayama H, Uematsu S, Okuzaki D, Osawa H, Haraguchi N, Uemura M, Hata T, Takemasa I, Mizushima T, Yamamoto H, Takeda K, Doki Y, Mori M.

Gastroenterology. 2013 Dec;145(6):1380-91.e1. doi: 10.1053/j.gastro.2013.08.049. Epub 2013 Aug 29.

PMID:
23993972
[PubMed - indexed for MEDLINE]
5.

Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.

Liu Z, Yang L, Cui Y, Wang X, Guo C, Huang Z, Kan Q, Liu Z, Liu Y.

Inflamm Bowel Dis. 2009 Aug;15(8):1133-44. doi: 10.1002/ibd.20923.

PMID:
19322899
[PubMed - indexed for MEDLINE]
6.

Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.

Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sørensen ES.

Scand J Immunol. 2007 May;65(5):453-60.

PMID:
17444956
[PubMed - indexed for MEDLINE]
7.

Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.

Rismo R, Olsen T, Cui G, Christiansen I, Florholmen J, Goll R.

Scand J Gastroenterol. 2012 May;47(5):538-47. doi: 10.3109/00365521.2012.667146.

PMID:
22486187
[PubMed - indexed for MEDLINE]
8.

The role of the novel Th17 cytokine IL-26 in intestinal inflammation.

Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM, Auernhammer CJ, Brand S.

Gut. 2009 Sep;58(9):1207-17. doi: 10.1136/gut.2007.130112. Epub 2008 May 15.

PMID:
18483078
[PubMed - indexed for MEDLINE]
9.

The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.

Liu Z, Yadav PK, Xu X, Su J, Chen C, Tang M, Lin H, Yu J, Qian J, Yang PC, Wang X.

J Leukoc Biol. 2011 Apr;89(4):597-606. doi: 10.1189/jlb.0810456. Epub 2011 Jan 7.

PMID:
21227898
[PubMed - indexed for MEDLINE]
Free Article
10.

TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.

Danese S, Sans M, Scaldaferri F, Sgambato A, Rutella S, Cittadini A, Piqué JM, Panes J, Katz JA, Gasbarrini A, Fiocchi C.

J Immunol. 2006 Feb 15;176(4):2617-24.

PMID:
16456024
[PubMed - indexed for MEDLINE]
Free Article
11.

Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

Ricciardelli I, Lindley KJ, Londei M, Quaratino S.

Immunology. 2008 Oct;125(2):178-83. doi: 10.1111/j.1365-2567.2008.02839.x. Epub 2008 Apr 16.

PMID:
18422560
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Perrier C, Arijs I, Staelens D, Breynaert C, Cleynen I, Covens K, Ferrante M, Van Assche G, Vermeire S, de Hertogh G, Schuit F, Rutgeerts P, Ceuppens JL.

Immunology. 2013 Jan;138(1):47-56. doi: 10.1111/imm.12014.

PMID:
23039249
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Relationship between serum infliximab trough levels and endoscopic activities in patients with Crohn's disease under scheduled maintenance treatment.

Imaeda H, Bamba S, Takahashi K, Fujimoto T, Ban H, Tsujikawa T, Sasaki M, Fujiyama Y, Andoh A.

J Gastroenterol. 2014 Apr;49(4):674-82. doi: 10.1007/s00535-013-0829-7. Epub 2013 May 11.

PMID:
23666424
[PubMed - indexed for MEDLINE]
14.

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.

Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, Kitazume MT, Nakazawa A, Sugita A, Koganei K, Isobe K, Hibi T.

Gut. 2008 Dec;57(12):1682-9. doi: 10.1136/gut.2007.135053. Epub 2008 Jul 24.

PMID:
18653729
[PubMed - indexed for MEDLINE]
15.

Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease.

Rismo R, Olsen T, Cui G, Paulssen EJ, Christiansen I, Johnsen K, Florholmen J, Goll R.

Scand J Gastroenterol. 2013 Mar;48(3):311-9. doi: 10.3109/00365521.2012.758773. Epub 2013 Jan 10.

PMID:
23302000
[PubMed - indexed for MEDLINE]
16.

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.

Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M.

Arthritis Res Ther. 2012 May 1;14(3):R99. doi: 10.1186/ar3824.

PMID:
22546542
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody.

Fuss IJ, Becker C, Yang Z, Groden C, Hornung RL, Heller F, Neurath MF, Strober W, Mannon PJ.

Inflamm Bowel Dis. 2006 Jan;12(1):9-15.

PMID:
16374252
[PubMed - indexed for MEDLINE]
18.

Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease.

Kanai T, Watanabe M, Okazawa A, Nakamaru K, Okamoto M, Naganuma M, Ishii H, Ikeda M, Kurimoto M, Hibi T.

Gastroenterology. 2000 Dec;119(6):1514-23.

PMID:
11113073
[PubMed - indexed for MEDLINE]
19.

Profile of soluble cytokine receptors in Crohn's disease.

Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Devière J, Franchimont D.

Gut. 2005 Apr;54(4):488-95.

PMID:
15753533
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.

Veny M, Esteller M, Ricart E, Piqué JM, Panés J, Salas A.

Aliment Pharmacol Ther. 2010 Mar;31(5):561-72. doi: 10.1111/j.1365-2036.2009.04209.x. Epub 2009 Dec 3.

PMID:
19958311
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk